Long‐term efficacy and safety of programmed death‐1 (PD‐1) antibody alone in relapsed/refractory human immunodeficiency virus‐associated Hodgkin lymphoma-Reference-Cited by-同舟云学术

Long‐term efficacy and safety of programmed death‐1 (PD‐1) antibody alone in relapsed/refractory human immunodeficiency virus‐associated Hodgkin lymphoma

Published:2022-05-04 Issue:3 Volume:3 Page:924-926
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Wang Chaoyu¹^ORCID,Zhou Fanlin²,Zhang Lingqian¹,Liu Tingting¹,Nan Yingyu¹,Liu Yao¹

Affiliation:

1. Department of Hematology Oncology Chongqing University Cancer Hospital, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment Chongqing China

2. Department of Pathology Chongqing University Cancer Hospital, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment Chongqing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.448

Reference7 articles.

1. Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies

2. Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection

3. Malignant lymphoma in the HIV-positive patient

4. Optimizing treatment of HIV-associated lymphoma

5. High‐dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors;Nademanee A;Blood,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-06-29

2. Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China;Infectious Agents and Cancer;2024-04-15

3. Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: results of a multicenter study from China;2024-01-02

4. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma;Frontiers in Nutrition;2022-11-10